预测肌危机结果的预测因素
Ahmad R Abuzinadah1,2, Mohammed H Alanazy3, Nadeem Shafique Butt4
1Department of Neurology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
维护类固醇节约性免疫抑制 (SSIS) 改善了肌危机 (MC) 的结果. 较低的普得尼松剂量 (<60mg/天) 可能会降低败血症风险,这是一种与长时间的ICU住院和通风相关的并发症.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 关键护理医学 关键护理医学
背景情况:
- 肌痛性危机 (MC) 管理需要仔细考虑免疫抑制策略.
- 维护类固醇节约性免疫抑制 (SSIS) 和普雷尼松剂量对MC结局的影响,包括败血症的发展,尚未确定.
- 了解这些因素对于优化MC期间的患者护理至关重要.
研究的目的:
- 调查维持SSIS和普得尼松剂量对肌危机结果的预测价值.
- 评估这些变量对MC患者败血症发展的影响.
主要方法:
- 这是一项回顾性多中心研究,分析了52名患者的数据,其中57名患者患有MC.
- 采用了单变量和多变量分析,包括混合效应逻辑回归和Cox比例危险回归.
- 关键的结果指标包括ICU停留时间和通风持续时间.
主要成果:
- 败血症与更长的ICU停留和通风持续时间 (HR:0.27-0.28) 有关.
- 败血症的预测因素包括50岁以上的年龄 (OR:7.74) 和在ICU停留期间高剂量普得尼松 (≥60mg/天) (OR:13.07).
- 在MC开始时的维护SSIS预测了更短的ICU停留和通风持续时间 (HR:2.23-2.73).
结论:
- 在MC开始时维持SSIS与改善的临床结果有关.
- 预防败血症和使用较低的普得尼松剂量 (<60毫克/天) 可以减轻风险并改善MC预后.
- 这些发现强调了定制免疫抑制策略在管理肌危机方面的重要性.
更多相关视频
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
09:44Manual Muscle Testing: A Method of Measuring Extremity Muscle Strength Applied to Critically Ill Patients
Published on: April 12, 2011
相关概念视频
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Myocarditis IV: Nursing Management
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
